Bibliographic
In this study the authors showed that vaccination with Abeta peptide 42 protects transgenic mice from the learning and age-related memory deficits that normally occur in this mouse model for Alzheimer's disease. The Abeta-vaccinated mice also had a partial reduction in the beta amyloid burden at the end of the study. This therapeutic approach may thus prevent and, possibly treat Alzheimer's dementia.